Regeneron Pharmaceuticals, Inc… (NASDAQ:REGN)

GettyImages_183162370

Large Companies With Fastest Revenue and Earnings Growth in 2015

This year is nearing the halfway mark and analysts are beginning to project their biggest winners and losers on the year. S&P Capital IQ recently released a report regarding the ...
Read Full Story »
biotech

The Most Loved Biotechs of Big Hedge Funds

With such a mixed performance over the past decade, some of us wonder why hedge funds are so revered. Ditto for many of the so-called guru fund managers. Still, investors ...
Read Full Story »
buy sell

5 Stocks Investors Must Watch in the Week Ahead

Stocks took a break from the six-year-old bull market last week. Still, investors want to own stocks, and they have aggressively bought every single sell-off for almost three years. 24/7 ...
Read Full Story »
biotech

The 5 Most Loved Biotech Stocks of Portfolio Managers

With the market continuing to grind higher, and the memories of the first time the Nasdaq hit 5,000 getting a fair amount of airplay and commentary, the question for most ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Box, BBVA, Freescale, Micron, Nordstrom and More

24/7 Wall St. reviews many fresh research calls each and every morning to find new investing and trading ideas for its readers. Some research reports cover stocks to Buy. Other ...
Read Full Story »
Biotechnology word cloud

Portfolio Managers Love These 5 Biotech Stocks

If there is one industry that had a busy January, it was biotech. In fact, January set an all-time record for issuance and funds raised in the biotech sector, and ...
Read Full Story »
Monkey evil

Top Analyst Upgrades and Downgrades: Crocs, Halliburton, Nuance, Staples, Yelp and More

Stocks were taking a steady breather going into the unemployment report after two major rallies in a row this week. What stands out is that investors keep proving that they will ...
Read Full Story »
Active investor

Insider Buying Still Strong During Year-End Holiday Week

With investors, both institutional and retail, down to their last days of trading for 2014 this past week, there were some spikes in trading volume that accompanied the normal slow ...
Read Full Story »
research

RBC’s 5 Top Biotech Stocks to Buy for 2015

As the year 2014 heads toward the finish line, many of the top Wall Street firms are sharpening their pencils and getting top ideas that make good sense for 2015 out ...
Read Full Story »
thumbs up

Credit Suisse Sees 2 Biotech Stocks That Could Double in 2015

Credit Suisse has released a biotech research report from analysts Jason Kantor and Jeremiah Shepard that has their top picks for upside potential in the biotech segment for 2015. The ...
Read Full Story »
Biotechnology word cloud

UBS Very Positive on Top Biotech Stocks Ahead of Earnings

The recent market sell-off spared no sector, and the top biotechnology stocks were treated with their own trip to the woodshed. Rising trends in prescriptions and higher, yet beatable increases ...
Read Full Story »
Biotechnology word cloud

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

Biotech stock investing can be a nerve-racking experience for investors, especially if they are focused on the companies that are waiting on some sort of binary event or clinical data ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Avago, Exelixis, Gap, Groupon, Staples, Tesla and More

Stocks were firm on Tuesday morning after the Labor Day weekend. Investors remain optimistic now that the DJIA has crossed 17,000 and after the S&P 500 hit 2,000 last week. ...
Read Full Story »
cash register, not full

Top Insider Selling of Stocks This Week from Biotech, Tech, Sam Zell, and More

In what was yet another very volatile week for the markets, insider selling and insider buying has been active. We have evaluated some of the top insider selling transactions this ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Apple, ARM, DaVita, GE, GoPro, Itron and Many More

Stocks were indicated to be weak on Monday, with some of the blame placed on sanctions and international pressure on Russia. Many investors are still looking for upside and sectors ...
Read Full Story »